death at discharge. [1] [2] [3] [4] 7, 8, [12] [13] [14] 16, 18 Data collection on the relationship between hospital volume and long-term mortality is highly warranted. This topic is of increasing interest as open surgeries for intracranial aneurysms are being replaced by endovascular procedures.
In this study we examined the relationship between hospital volume and 1-year mortality after surgical and endovascular treatment for ruptured and unruptured intracranial aneurysms in hospitals across Denmark, Norway, and Sweden.
methods study population
Scandinavia consists of the 3 countries Denmark, Norway, and Sweden, with a combined population of 19.5 million inhabitants. All neurosurgical and endovascular treatments of intracranial aneurysms are regionalized to public hospitals with neurosurgical departments. Patients with verified aneurysmal subarachnoid hemorrhage (SAH) are usually accepted for immediate admission to one of the hospitals with neurosurgical service, independent of age and clinical condition. The exceptions are patients considered in a moribund state after exclusion of acute hydrocephalus by CT.
data source
The patient registries of Denmark, Norway, and Sweden contain data on all inpatient care in each respective country. We collected data from the patient registries on all patients ≥ 18 years old with a national identity number who were admitted to hospitals in Denmark, Norway, and Sweden. We included patients admitted from January 1, 2002, to December 31, 2010, in Denmark and Sweden. For Norway, we included patients admitted from January 1, 2008, to December 31, 2010. This difference in dates was because the Norwegian hospital discharge registry only included person-identifiable data from 2008 onwards. The study was approved by the Regional Committee for Medical and Health Research Ethics North in Norway, and by the patient registries of Denmark, Norway, and Sweden.
inclusion criteria for ruptured intracranial aneurysm
We included 5773 patients ≥ 18 years of age with an emergency admission, a discharge diagnosis of SAH (International Classification of Diseases, 10th revision [ICD-10] codes I60.0-I60.7 and I60.9), and a procedure code for surgical or endovascular treatment of an intracranial aneurysm (NOMESCO Classification of Surgical Procedures [NCSP] codes AAC00-AAC15 [surgery] and AAL00 [endovascular]).
inclusion criteria for unruptured intracranial aneurysm
We included 1807 patients ≥ 18 years of age with a planned admission, a discharge diagnosis of unruptured intracranial aneurysm (ICD-10 code I67.1), and a procedure code for surgical or endovascular treatment of an intracranial aneurysm (NCSP codes AAC00-AAC15 [surgery] and AAL00 [endovascular]). We excluded 51 patients with prior SAH (secondary discharge diagnosis of sequelae of SAH, ICD-10 code I69.1, or prior admission for ruptured intracranial aneurysm in our dataset) to reduce the possibility that recovery from previous SAH would affect the results. This left 1756 patients with unruptured intracranial aneurysms available for analysis.
data collection
For each patient we collected the following data: age, sex, dates of admission and discharge, primary and secondary diagnosis codes, procedure codes, and hospital. Based on the secondary diagnoses, we calculated the Charlson Comorbidity Index (CCI), a widely used measure for classifying comorbid conditions that alter the risk of death. 6 For patients with repeat admissions, we used the data from the first admission.
We obtained data on date of death for each patient up to December 31, 2011, by linkage of the hospital discharge registry and the population registry in each respective country, using the patient's unique personal identification number. Record linkage was conducted at each patient registry. Follow-up duration was set at 12 months after the date of admission or until death occurred within the 12-month follow-up period.
statistical analysis
We calculated descriptive statistics for patients with ruptured and unruptured intracranial aneurysms separately. For each hospital, we calculated average annual volume of patients and 1-year mortality rates. We used the Kruskal-Wallis test to examine whether mortality differed across year of admission, hospital, and country. We used Poisson regression to calculate age-adjusted 1-year mortality for each hospital and plotted the age-adjusted 1-year mortality for each hospital against the average annual volume of patients in the corresponding hospital.
We used Cox regression analysis to calculate hazard ratios (HRs) and 95% confidence intervals (CIs), with time until death as the dependent variable. We assessed hospital volume as a continuous variable and as a categorical variable in 3 tertile groups. For ruptured intracranial aneurysms, the 3 tertile groups were: 5 hospitals in the lowest tertile (6.2-36.0 patients per year); 5 hospitals in the intermediate tertile (43.8-62.4 patients per year); and 5 hospitals in the highest tertile (63.1-118.0 patients per year). For unruptured intracranial aneurysms, the 3 tertile groups were: 5 hospitals in the lowest tertile (2.9-10.9 patients per year); 5 hospitals in the intermediate tertile (14.3-19 .7 patients per year); and 5 hospitals in the highest tertile (21.9-45.6 patients per year). The p value for trend was calculated by entering the categorical variable of hospital volume as a continuous variable in the regression models. The analyses were performed unadjusted and adjusted for age, sex, surgical treatment, CCI, year of treatment, and country. We fitted age as a continuous variable, sex and surgical treatment as dichotomous variables, and CCI (0, 1, or 2), country (Denmark, Norway, and Sweden), and year of treatment as categorical variables. The proportional hazards assumption was verified using Schönfeld's residuals and by inspection of log-log plots.
All analyses were preplanned and conducted separate-ly for patients with ruptured and unruptured intracranial aneurysms. We had also planned to use propensity-score matching to compare mortality rates between patients treated at low-and high-volume hospitals, but the low number of patients treated at low-volume hospitals precluded these analyses. As data from Norwegian hospitals were first available from 2008, we performed additional analyses restricted to patients admitted between 2008 and 2010. We used a 5%, 2-sided level of significance and analyzed the data with STATA (version 12, StataCorp).
results
We included 5773 patients treated for ruptured intracranial aneurysms and 1756 patients treated for unruptured intracranial aneurysms from a total of 15 hospitals in Denmark, Norway, and Sweden between 2002 and 2010. Baseline characteristics of the patients are given in Table 1 . The average annual volume for each hospital is given in Fig. 1 . The average annual number of treatments varied from 6.2 to 118 patients per year for ruptured intracranial aneurysms and from 2.9 to 45.6 patients per year for unruptured intracranial aneurysms.
ruptured intracranial aneurysms
For patients with ruptured intracranial aneurysms, 1-year mortality across all hospitals was 15.6%, and varied from 4.7% to 21.4% among the hospitals (p < 0.01, Kruskal-Wallis test). Mortality did not change across year of admission (p = 0.21, Kruskal-Wallis test). One-year mortality by mean hospital volume, adjusted for age, is shown in Fig. 2 upper.
Hazard ratios for 1-year mortality by hospital volume are given in Table 2 . No clear relationship between hospital volume and mortality was observed in the unadjusted analyses. In the analyses adjusted for potential confounders, we observed a small statistically significant relationship between increasing hospital volumes and higher 1-year mortality (p = 0.04). Figure 3 upper shows ageadjusted cumulative mortality by hospital volume tertile.
unruptured intracranial aneurysm
For patients with unruptured intracranial aneurysms, 1-year mortality across all hospitals was 2.7%, and varied from 0% to 5.6% between the hospitals (p < 0.01, KruskalWallis test). Mortality did not change across year of admission (p = 0.98, Kruskal-Wallis test). One-year mortality by mean hospital volume, adjusted for age, is given in Fig. 2 lower.
Hazard ratios for 1-year mortality by hospital volume are given in Table 2 . We found an inverse relationship between hospital case volume and 1-year mortality in the unadjusted analyses. Similar HRs were observed after adjustment for potential confounders, but the association between hospital volume and 1-year mortality was no longer statistically significant. Figure 3 lower shows age-adjusted cumulative mortality by hospital volume tertile.
between-country differences in mortality
Hazard ratios for 1-year mortality by country are given in Table 3 . Mortality for both ruptured and unruptured aneurysms varied significantly between patients from Denmark, Norway, and Sweden. The between-country differences remained statistically significant after adjustment for potential confounders.
additional analyses
Analyses restricted to patients admitted between 2008 and 2010 provided similar directions of the effect size for the relationship between hospital volume and mortality after treatment compared with the original analyses. For ruptured intracranial aneurysms, the HR per 10-patient increase was 1.02 (95% CI 0.98-1.06). For unruptured intracranial aneurysms, the HR per 10-patient increase was 0.48 (95% CI 0.31-0.85).
Analyzes stratified by treatment modality (endovascular and surgical) found similar directions in the effect size for the relationship between hospital volume and mortality after treatment of both ruptured intracranial aneurysms 
discussion
The main findings of the present study are that hospital volume was not consistently associated with 1-year mortality after treatment for ruptured intracranial aneurysms, whereas there was a trend toward lower mortality after treatment for unruptured intracranial aneurysms in high-volume hospitals. Furthermore, there were large differences in long-term (1-year) mortality across hospitals and between the 3 Scandinavian countries.
Our study adds to the literature by being the first to examine the relationship between hospital volume and longterm mortality after treatment of intracranial aneurysms. Most previous studies of hospital volume and mortality after treatment for unruptured and ruptured intracranial aneurysms have found lower mortality in high-volume compared with low-volume hospitals, but different definitions of "low-volume hospital" make direct comparison with our study difficult. [1] [2] [3] [4] 7, 8, 13, 14, [16] [17] [18] All previous studies except 1 have reported mortality at discharge. The lower mortality in high-volume hospitals may therefore have been confounded, for instance, by differences in length of stay and discharge routines. [1] [2] [3] [4] 7, 8, [12] [13] [14] 16, 18 Furthermore, all previous studies except 2 originated in the US and the analyses include data from hospitals where multidisciplinary neurosurgical care is likely to be less available or absent. [1] [2] [3] [4] 7, 8, 13, 14, 16, 18 Results from these studies may not be generalizable to health care systems in other countries where specialist neurosurgical services are centralized to tertiary regional hospitals with a defined population and patients are referred from smaller hospitals. A possible explanation for the differences between our results and those published from the US is that all treatments of intracranial aneurysms in Scandinavia are performed at academic hospitals by specialized cerebrovascular surgeons and interventional neuroradiologists, whereas neurosurgeons working in low-volume hospitals in the US may be more likely to be general neurosurgeons than specialized cerebrovascular surgeons.
Two previous studies have examined the relationship between hospital volume and outcome after aneurysm treatment in a health care system where specialist neurosurgical services are delivered at tertiary regional hospitals with a defined population. 12, 17 One study from Japan found no relationship between hospital volume and functional outcome (Glasgow Outcome Scale score) at discharge after treatment of ruptured and unruptured intracranial aneurysms. 12 One study from the United Kingdom examined the relationship between hospital volume and 6-month mortality after (aneurysmal and nonaneurysmal) SAH. 17 This study found a relationship between hospital volume and mortality, but the use of aggregated data, lack of adjustment for age or other prognostic factors, and inclusion of patients with nonaneurysmal SAH limit the generalizability of the results. We found no consistent relationship in our study between hospital volume and mortality after treatment for ruptured intracranial aneurysms, but there was a trend toward lower mortality after treatment for unruptured intracranial aneurisms in high-volume hospitals. We believe a plausible explanation for this finding is that surgical experience is more directly associated with outcome after treatment for unruptured intracranial aneurysms because these patients are otherwise healthy and undergo planned surgery. In comparison, other factors that are not related to the surgical experience (such as severity of the SAH, prehospital care, and rehabilitation) may be more important contributors to outcome after treatment for ruptured intracranial aneurysms than hospital volume.
Our findings do not support centralization of treatment for ruptured intracranial aneurysms to high-volume centers. However, we found large between-hospital and between-country variations in mortality after surgical and endovascular treatment of both ruptured and unruptured intracranial aneurysms. The cause for this is unknown. Although the variations in mortality may reflect differences in quality of care, an equally possible explanation is differences in unmeasured prognostic factors (confounding by indication). 15 For instance, some hospitals may have a more aggressive treatment approach for severe SAH (which has a poor prognosis) or for small, unruptured intracranial aneurysms (which has an excellent prognosis). Appropriate selection criteria for treatment are important, especially for unruptured intracranial aneurysms in which the decision to treat involves a tradeoff between the immediate surgical risk and the long-term risk of rupture. Studies from patient registries are unable to adjust for differences in selection to treatment as they lack data on important prognostic factors such as disease severity and aneurysm morphology. Prospective registries for evaluating patient outcomes after treatment for intracranial aneurysms are therefore highly warranted. Such a registry is currently being established in Norway.
The differences in mortality between hospitals should be interpreted with caution as some hospitals' samples were small and extreme outcomes (both high and low) are likely to occur randomly in small samples. 20 From the patient's perspective, this may be of importance and favor undergoing treatment at larger-volume hospitals, as small sample sizes make it more difficult to determine the quality and safety of surgery in low-volume compared with high-volume hospitals. We also observed a large difference in the use of surgical treatment for ruptured intracranial aneurysms between high-and low-volume hospitals, which may reflect differences in the availability of interventional neuroradiology services 24 hours a day.
Our study has important limitations. First, all hospital discharge registries are prone to errors in coding. To reduce the risk of erroneous classification of cases, we used diagnosis codes, procedure codes, and whether the patient was admitted as an emergency to classify the cases as ruptured or unruptured intracranial aneurysms. Second, because of this approach, we did not include patients with intracranial aneurysms who did not undergo surgical or endovascular treatment. Selection criteria for treatment may vary across hospitals and could have influenced the results. Third, we calculated the CCI based on the secondary discharge diagnoses. These diagnoses likely do not fully reflect the patients' comorbidities. Fourth, we did not have data on functional outcome. Functional outcome may be of more interest than mortality, especially for patients 
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The limitations of our study are numerous, but similar limitations (use of hospital discharge data, lack of adjustment for prognostic factors such as aneurysm morphology and disease severity, and lack of data on functional outcome) pertain to all prior studies that examined the relationship between hospital case volume and mortality after aneurysm treatment, [1] [2] [3] [4] 7, 8, 13, 14, [16] [17] [18] except one. 12 Furthermore, although it is possible that more complex aneurysms are transferred to higher-volume centers, we believe this selection bias is less likely to affect the results from Scandinavia than those from the US because each hospital in Scandinavia treats a population in a defined geographic region. Although our findings may be controversial, they are consistent with the only previous study that has adjusted for disease severity. 12 This study did not find a statistically significant relationship between hospital volume and outcome after treatment for ruptured intracranial aneurysms. 12 Compared with previous studies, our study has important strengths, including a large, population-based sample with long-term follow-up through linkage with population registries. Furthermore, we used individual patient data and adjusted for age, sex, year of treatment, treatment type, and the CCI.
conclusions
Our findings did not confirm a relationship between higher hospital volume and reduced long-term mortality after treatment of ruptured intracranial aneurysms. Furthermore, we observed significant differences in betweenhospital and between-country mortality rates. Prospective registries for evaluating patient outcomes after treatment for intracranial aneurysms are highly warranted.
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